Octave 10-Q: Q3 Revenue $415M, $2.13B Impairments, Material Weaknesses Persist
OCTV sits 39% above its 52-week low of $15.41.
Summary
Octave's Q3 10-Q confirms $415 million of revenue and a $1.17 billion ARR, but the real news is a $1.86 billion nine-month GAAP loss from $2.13 billion of non-cash impairments, two still-unremediated material weaknesses in internal control, and $520 million of new term debt taken on to fund the Hexagon separation payment.
Key Events · Earnings and Guidance · OCTV
-
Q3 Revenue $415M, Up 6%
Total revenue of $415.3 million rose 6% year over year with gross margin flat at 75%; SaaS revenue grew 18% to $91.4 million while licenses fell 4%.
-
$2.13B Non-Cash Impairments Drive Loss
Nine-month net loss was $1,864.3 million, including $1,671.0 million of goodwill impairment and $463.7 million of trademark impairment, both non-cash and excluded from covenant compliance.
-
Material Weaknesses Still Unremediated
Management concluded disclosure controls were not effective at September 30, 2026 due to two material weaknesses — manual journal entry segregation of duties and IT general controls — identified before the spin-off.
-
$520M Term Debt From Spin Separation
Term loans of $520.2 million principal ($518.5 million net) were drawn May 22, 2026 to fund the $625.0 million cash payment to Hexagon; another $125.0 million was drawn November 9 for the Cerebre acquisition, leaving $375.0 million available.
Analysis · OCTV · Technology
The headline numbers match the 8-K, but the 10-Q carries the substance behind them. Nine-month GAAP results show a $1,864.3 million net loss driven almost entirely by $2,134.7 million of non-cash impairment charges — $1,671.0 million of goodwill and $463.7 million of trademarks written down after the post-spin market cap sat below carrying value. Underlying operations are fine: Q3 revenue rose 6% to $415.3 million, gross margin held at 75%, and adjusted operating margin was 28%. The bigger issue for holders is governance. Management states disclosure controls were not effective at September 30, 2026 because two material weaknesses identified before the spin — manual journal entry segregation of duties and IT general controls — remain unremediated. The balance sheet is newly levered: $520.2 million of term loans were drawn to fund the $625.0 million cash payment to Hexagon, and another $125.0 million was borrowed November 9 to buy Cerebre. Cash of $297.0 million plus $375.0 million of remaining revolver capacity covers the next twelve months, and the $200 million buyback authorized November 11 is aimed at offsetting equity-compensation dilution rather than shrinking the share count.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OCTV was trading at $21.46 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $15.41 to $27.39. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.